CF Fungal Disease in the Age of CFTR Modulators.
CF Fungal Disease in the Age of CFTR Modulators.
复制标题
DOI：
10.1007/s11046-021-00541-5
复制
发表时间：
2021-10
期刊：
影响因子：
5.5
通讯作者：
Shah A
中科院分区：
文献类型：
--
作者：
Bercusson A;Jarvis G;Shah A
Fungi are increasingly recognised to have a significant role in the progression of lung disease in Cystic fibrosis with Aspergillus fumigatus the most common fungus isolated during respiratory sampling. The emergence of novel CFTR modulators has, however, significantly changed the outlook of disease progression in CF. In this review we discuss what impact novel CFTR modulators will have on fungal lung disease and its management in CF. We discuss how CFTR modulators affect antifungal innate immunity and consider the impact of Ivacaftor on fungal disease in individuals with gating mutations. We further review the increasing complication of drug–drug interactions with concurrent use of azole antifungal medication and highlight key unknowns that require addressing to fully understand the impact of CFTR modulators on fungal disease.
登录
查看更多内容
影响因子：
6.1
作者：
Agarwal, R.;Chakrabarti, A.;Denning, D. W.
通讯作者：
Denning, D. W.
影响因子：
4
作者：
Bedke, Tanja;Iannitti, Rossana G.;Topp, Max S.
通讯作者：
Topp, Max S.
影响因子：
5.2
作者：
Abdolrasouli A;Petrou MA;Park H;Rhodes JL;Rawson TM;Moore LSP;Donaldson H;Holmes AH;Fisher MC;Armstrong-James D
通讯作者：
Armstrong-James D
影响因子：
6.1
作者：
Becker, K. L.;Gresnigt, M. S.;van de Veerdonk, F. L.
通讯作者：
van de Veerdonk, F. L.
影响因子：
2.6
作者：
Berge, M.;Guillemain, R.;Billaud, E. M.
通讯作者：
Billaud, E. M.